Atlas Venture Life Science Advisors, LLC Day One Biopharmaceuticals, Inc. Transaction History
Atlas Venture Life Science Advisors, LLC
- $443 Million
- Q3 2025
A detailed history of Atlas Venture Life Science Advisors, LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Atlas Venture Life Science Advisors, LLC holds 6,430,257 shares of DAWN stock, worth $56.6 Million. This represents 10.23% of its overall portfolio holdings.
Number of Shares
6,430,257
Previous 6,430,257
-0.0%
Holding current value
$56.6 Million
Previous $41.8 Million
8.46%
% of portfolio
10.23%
Previous 9.19%
Shares
6 transactions
Others Institutions Holding DAWN
# of Institutions
179Shares Held
70.5MCall Options Held
42.8KPut Options Held
60.3K-
Vanguard Group Inc Valley Forge, PA6.18MShares$54.4 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY4.71MShares$41.4 Million0.62% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$39.9 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.48MShares$30.6 Million0.01% of portfolio
-
Rubric Capital Management LP New York, NY3.38MShares$29.7 Million0.39% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $646M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...